Under the terms of the merger agreement, Radiation Therapy Services shareholders are entitled to receive $32.50 in cash, without interest, for each share of Radiation Therapy Services common stock held.
Daniel Dosoretz, CEO of Radiation Therapy, said: “We are pleased to partner with a prominent private equity firm that shares our commitment to the company and its mission of delivering the highest quality of care.”